SOPH

SOPHiA GENETICS SA Ordinary Shares (SOPH)

Stock · NASDAQ · Technology

$6.75as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum. Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.

Active signals

Support level
$4.79
Industry
EDP Services

What SOPH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume SpikeActive now50+1.1%52%
Bollinger Band Breakout25-2.6%40%
Bollinger Band BreakdownActive now17+12.7%76%
200-Day Moving Average TouchActive now6+3.2%67%
Any 20-session window (baseline)+1.0%54%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SOPH

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through…

Sector
Technology
Industry
EDP Services
Employees
415

Fundamentals

1-day range
$6.83$7.34
Market cap
$569.51M
P/E (trailing)
—
P/E (forward)
-14.54
EPS (trailing)
$-1.15
Dividend yield
—
Beta
1.06
Avg. volume
558.1K
52-week range
$3.75$8.98
Next earnings: November 3, 2026 · EPS estimate $-0.20confirmed

Forecasts

4 analyst ratings

Buy 91%
Hold 9%
Sell 0%
1-year price forecast
High
$14
+107.4%
Median
$9
+33.3%
Low
$7
+3.7%

SOPHiA GENETICS SA Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • SOPH
    SOPHiA GENETICS SA Ordinary Shares
    $6.73
    ▼ 7.68%
    Market cap $569.51MP/E —
    $3.75$8.98
  • YEXT
    Yext Inc. Common Stock
    $6.9
    ▼ 3.23%
    Market cap $558.38MP/E 25.73
    $3.27$9.03
  • NRDS
    NerdWallet Inc. Class A Common Stock
    $10.02
    ▼ 0.05%
    Market cap $581.66MP/E 9.86
    $7.33$16.24
  • OOMA
    Ooma Inc. Common Stock
    $19.72
    ▼ 3.71%
    Market cap $588.50MP/E 51.21
    $9.79$26.19
  • DDI
    DoubleDown Interactive Co. Ltd. American Depository Shares
    $13.8
    ▲ 0.55%
    Market cap $589.69MP/E 5.08
    $8.1$13.9
  • OSPN
    OneSpan Inc. Common Stock
    $17.5
    ▼ 2.07%
    Market cap $598.48MP/E 9.53
    $10.07$18.83
  • IBEX
    IBEX Limited Common Shares
    $45.65
    ▼ 0.58%
    Market cap $494.86MP/E 12.76
    $25.94$45.28

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
4.6K
Disposed
136.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.